Stay updated on Risankizumab Autoinjector Usability Clinical Trial

Sign up to get notified when there's something new on the Risankizumab Autoinjector Usability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab Autoinjector Usability Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The NIH transition announcement banner was removed from the top of the page.
    Difference
    1%
    Check dated 2026-11-09T13:16:13.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:50:08.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The study page no longer shows the 403 error screen and instead displays the site framework with a notice about NIH terminology changes. No clinical-trial details are shown.
    Difference
    2%
    Check dated 2026-10-26T12:56:13.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T13:28:21.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:19:16.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of showing the study record, indicating the page is currently inaccessible. This change affects access to the page rather than the underlying study content.
    Difference
    18%
    Check dated 2026-09-21T22:32:30.000Z thumbnail image

Stay in the know with updates to Risankizumab Autoinjector Usability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab Autoinjector Usability Clinical Trial page.